Welcome to our dedicated page for HealWELL AI news (Ticker: HWAIF), a resource for investors and traders seeking the latest updates and insights on HealWELL AI stock.
HEALWELL AI Inc. (OTCQX: HWAIF; TSX: AIDX) regularly issues news updates as a healthcare artificial intelligence company focused on preventative care and early disease detection. Its announcements describe how the company is developing and commercializing proprietary clinical decision support systems and AI platforms intended to help healthcare providers detect rare and chronic diseases, improve efficiency, and support better patient outcomes.
News releases from HEALWELL cover a range of topics, including financial and operational updates, strategic acquisitions and divestments, and progress in integrating acquired businesses such as Orion Health. The company has reported a transition toward a pure-play digital SaaS, services and AI business focused on health systems and large enterprise customers, and its news flow reflects this emphasis on enterprise-grade healthcare software and data science offerings.
HEALWELL’s news also highlights developments in its AI platforms, including the DARWEN™ AI system and the launch of AmadeusAI, an AI-enabled digital care record built on Orion Health’s Amadeus platform. Announcements have described new AI tools such as SMARTSearch, SMARTSummary, and SMARTIdentify, as well as collaborations with public health organizations, healthcare systems, and life sciences partners.
Investors and observers can use this news page to follow HEALWELL’s disclosures on corporate transactions, joint ventures, memoranda of understanding, recognition of its AI technologies in peer-reviewed studies, and participation in industry and investment conferences. The updates provide context on how the company presents its strategy in preventative healthcare AI, its focus on real-world data and evidence generation, and its orientation toward large-scale health system and enterprise deployments.
HEALWELL AI (OTCQX: HWAIF) reported record fiscal 2025 results with $103.8M revenue, a 427% increase year-over-year, and its first full year of positive Adjusted EBITDA at $2.3M. The company reported an IFRS net loss of $39.1M and ended the year with $18.6M cash.
HEALWELL completed strategic divestments generating $9.7M in cash, integrated Orion Health, and highlighted DARWEN's scientific validation with 47 peer-reviewed publications.
HEALWELL AI (OTCQX:HWAIF) announced its 47th peer-reviewed publication validating the DARWEN™ AI platform, with new research published in the Journal of Crohn's and Colitis and presented at ECCO on March 12, 2026. HEALWELL also secured three additional 2026 conference acceptances across diabetes, dermatology and IBD.
The studies show DARWEN™ can transform unstructured EHR data into research-ready real-world evidence, analyze millions of clinical records, and support Medical Affairs and market access initiatives with pharmaceutical partners.
HEALWELL AI (TSX: AIDX) (OTCQX: HWAIF) will release its Fiscal Fourth Quarter and Year End 2025 financial results for the period ended December 31, 2025, on March 19, 2026. A conference call and simultaneous webcast to discuss results will be held on March 20, 2026 at 8:30 AM ET.
Management hosting the call: James Lee, Chief Executive Officer; Dr. Alexander Dobranowski, President; and Anthony Lam, Chief Financial Officer. Webcast and dial-in details provided for live access.
HEALWELL AI (OTCQX: HWAIF) announced a signed multi‑million dollar, multi‑year U.S. Health Information Exchange (HIE) software contract, expanding its enterprise interoperability footprint and supporting secure data exchange for millions of patient lives.
The company reported renewed pipeline momentum, coordinated Orion Health and VeroSource bid activity, and integration of SMART Identify, SMART Search and SMART Summary into the Amadeus AI platform to drive enterprise AI commercialization.
HEALWELL (OTCQX:HWAIF) will participate in three investor conferences in March 2026: TD Cowen (Boston, Mar 2-4), Scotiabank TMT (Toronto, Mar 3-4) and ROTH (Dana Point, Mar 22-24).
Dr. Alexander Dobranowski will present and hold investor meetings, including a TD Cowen presentation on Mar 3 and a ROTH panel on Mar 23 titled Technologies Advancing Healthy Aging.
HEALWELL AI (OTCQX:HWAIF) announced its first contracted AI deployment in the Middle East and expanded active deployments across Canada and the United States on February 26, 2026. The Company is deploying SMART Identify, SMART Search, and SMART Summary in multiple healthcare systems, marking cross‑border commercial momentum and platform scalability.
HEALWELL says deployments span frontline care environments and that contracted revenue now exists across Canada, the U.S., and the Middle East, while the company reports a growing pipeline for broader enterprise expansion.
HEALWELL AI (OTCQX: HWAIF) and WELL Health launched WELLTRUST™ on February 19, 2026, a consent-first data governance and patient-identification platform deployed across WELL-operated clinics in Canada. WELLTRUST uses patient-controlled consent and HEALWELL's DARWEN™ AI to identify high-fit patients for clinical trials while preserving privacy and compliance.
The platform supports contact consent, unified privacy controls, AI-enabled recruitment, and a governance layer to meet Canadian regulatory standards.
HEALWELL AI (OTCQX: HWAIF) provided a corporate update on February 12, 2026, outlining platform integration, product rollouts and portfolio simplification.
The company unified Khure and Pentavere into a DARWEN-powered AI engine, plans a North American Amadeus AI launch in 1H-26 (international late 2026), reports early commercial traction via Orion-Verosource initiatives, notes four Q4-2025 publications, and is assessing a USD $2M strategic investment vehicle holding an interest in xAI/SpaceX.
HEALWELL AI (OTCQX: HWAIF) provided additional disclosure after an OSC request to clarify forward-looking statements tied to its November 3, 2025 strategic divestments.
Key factual points: continuing-operations revenue of $30.4M in Q3-2025 (annualized ≈ $120M), a Q3-2025 Adjusted EBITDA of $0.7M versus an Adjusted EBITDA loss of $2.8M in Q3-2024, and a net loss from continuing operations of $16M in Q3-2025. The company completed sales of two non-core businesses and contributed two others to a clinical research joint venture following the Orion Health acquisition (effective April 1, 2025).
The company emphasized assumptions and risks underlying its revenue run-rate and AI capability claims and referenced peer-reviewed validations and industry awards for its DARWEN platform.
HEALWELL AI (OTCQX: HWAIF) appointed Ian Kidson to its Board of Directors, effective December 10, 2025.
Kidson brings decades of financial, governance, and healthcare-related corporate leadership across public and private companies in Canada and the U.S., including roles as CFO at Docebo (2019–2021), CFO and CEO at Apollo Health Corp., EVP & CFO at Progressive Waste Solutions (before its 2016 merger with Waste Connections), and senior capital markets positions at CIBC Wood Gundy and TD Capital Mezzanine Partners. HEALWELL said his financial expertise and experience guiding organizations through growth will support its focus on early identification and detection of disease.